Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy. (Q39671969)
Jump to navigation
Jump to search
scientific article published on 3 August 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy. |
scientific article published on 3 August 2010 |
Statements
Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy (English)
Clara Albanese
Rachele Alzani
Nadia Amboldi
Nilla Avanzi
Dario Ballinari
Maria Gabriella Brasca
Claudio Festuccia
Francesco Fiorentini
Giuseppe Locatelli
Wilma Pastori
Veronica Patton
Fulvia Roletto
Arturo Galvani
Antonella Isacchi
Jurgen Moll
Enrico Pesenti
Ciro Mercurio